Oikawa, H., Sasaki, M., Ehara, S., Abe, T., 2004. Substantia innominata: MR findings in Parkinson's disease. Neuroradiology 46, 817-821. ANATOMY Gratwicke et al. / Neuroscience and Biobehavioral Reviews 37 (2013) : NBM is aflat, nearly horizontal structure extending from the olfactory tuber-cle anteriorly to the level of the uncal hippocampus at its most caudal extent, spanning a distance of 13-14 mm in the sagittal plane. It reaches its greatest cross-sectional diameter under theanterior commissure in a region known as the substantia innomi-nata, with a medio-lateral width of 16-18 mm (Mesulam and Geula,1988) . In its anterior portion the nucleus is limited inferiorly by thehorizontal limb of the nucleus of the diagonal band of Broca, supero-medially by the ventral globus pallidus, and supero-laterally by thelateral extension of the anterior commissure ( Figs. 1 and 2) . In its posterior portion it abuts the ansa lenticularis superiorly, the puta-men laterally, the posterior tip of the amygdala inferiorly, and the optic tract medially (Fig. 2) (Mesulam and Geula, 1988; Rossor et al.,1982) .
Gratwicke et al. / Neuroscience and Biobehavioral Reviews 37 (2013): Representation of the major anatomical structures and fibre tracts related to the nucleus basalis of Meynert (Ch4, in red) in the human basal forebrain region. Overlying structures have been lifted upward to expose the NBM, as indicated by dashed grey lines. The major subsectors of the NBM are shown within the nucleus; their approximate anatomical boundaries are indicated by dashed black lines. The diagram is based on anatomical observations in the human brain by Mesulam and Geula (1988) and Rossoret al. (1982) . A = amygdala; AC = anterior commissure (lateral aspect); AL = ansa lenticularis; Ch3 = horizontal limb nucleus of the diagonal band of Broca (cholinergic cell group 3 of the basal forebrain); GPi = globus pallidus internus; GPe = globus pallidus externus; OT = optic tract; P = putamen; uH = uncal hippocampus. Subsectors of NBM as described in the main text, NSP = nucleus subputaminalis.
NUCLEUS BASALIS OF MEYNERT

A136 (2)
CONNECTIVITY Gratwicke et al. / Neuroscience and Biobehavioral Reviews 37 (2013) : Anatomical diagram of the left hemisphere demonstrating location of the nucleus basalis of Meynert and its major projecting cholinergic pathways in the humanbrain. The medial surface of the left hemisphere is closest to the viewer. A coronal section is presented at approximately 6 mm posterior to the midpoint of the anteriorcommissure. The diagram is based on anatomical observations in the human brain by Selden et al. (1998) and human diffusion tensor imaging studies by Hong and Jang(2010). A = amygdala; AC = anterior commissure (lateral aspect); C = caudate; Cg = Cingulate gyrus; F = frontal lobe (medial surface); GPi = globus pallidus (internus); IN = insularcortex; NBM = nucleus basalis of Meynert; Oc = occipital lobe (medial surface); OF = orbitofrontal cortex; P = putamen; Pr = parietal lobe (medial surface).
The efferent connectivity between individual subsec-tors of NBM and cortical areas displays a topographic specificityaccording to both retrograde tracer experiments in the primate andneuropathological studies in human AD patients ( Fig. 3 ): Ch4amprovides the major cholinergic projection to frontal, parietal andcingulate cortices situated along the medial wall of the hemisphere.Lesser projections are directed to the hypothalamus, hippocampalformation, ventral somatosensory cortex, amygdala, ventrolateralorbital, middle insular, periarcuate, peristriate, parahippocampalregions and the inferior parietal lobule. The Ch4al subsector is theprincipal source of cholinergic projections to frontoparietal oper-cular regions and the amygdala. Additional projections are directedto the olfactory bulb, medial frontal pole, dorsomedial motor cor-tex, ventrolateral orbital cortex, insular, inferotemporal area andparahippocampal regions. The Ch4id and Ch4iv subsectors havesimilar projection patterns: they give prominent projections toventrolateral orbital, insular, periarcuate, peristriate, inferotempo-ral, and parahippocampal areas as well as to the inferior parietallobule. Minor projections occur to the medial frontal pole, dorso-medial motor cortex, frontoparietal opercular areas, the amygdala,anterior auditory cortex, and the temporal pole. Lastly the Ch4psubsector has a more restricted major projection to the superiortemporal gyrus and the temporal pole. Its lesser projections areconfined to adjacent inferotemporal and posterior insular regions (Jones et al., 1976; Mesulam and Geula, 1988; Mesulam et al., 1983) .Efferent cholinergic fibres from the human NSP course in the exter-nal capsule towards the inferior frontal gyrus, which lead Simicet al. to propose that it projects to the cortical speech area in man (Simi´c et al., 1999) .The complex topographical arrangement of Ch4 efferent con-nectivity also contains considerable overlap between individualsubsectors according to primate tracing studies. Some corticalareas, such as the ventrolateral orbital, insular, parahippocam-pal and peristriate cortices, receive projections of comparable sizefrom many different Ch4 subsectors (Mesulam et al., 1983) . Thismay allow for some redundancy in the system, which could pre-vent these cortical areas from substantial cholinergic denervationshould one Ch4 subsector be preferentially affected by disease. Onthe other hand, other cortical regions such as medial frontoparietal,superior temporal and temporopolar regions receive Ch4 projec-tions from a much more restricted number of subsectors, and couldtherefore be much more vulnerable to cholinergic denervation fol-lowing limited NBM cell loss in those areas. This is supported byobservations in human post-mortem brain tissue which show thatthere is secondary degeneration in the nucleus basalis followingtemporal lobe lesions, but not after frontal or parietal lobe lesions (Kodama, 1929) .
The major proposed connections of the human NBM with cortical and subcortical structures (see text for details). Major afferent projections (bright green arrows)are inputs to NBM as a whole: catecholaminergic projections from VTA, SNpc, retrorubral field, raphe nuclei and locus coeruleus; serotonergic projections from dorsal raphenuclei and VTA; cholinergic projections from pedunculopontine nucleus. Major efferent projections (bright red arrows) are shown according to their principle NBM subsectorof origin. Most NBM subsectors have additional minor projections which overlap with the cortical target fields of other subsectors, creating redundancy in the topographicalarrangement of projections (these are not shown but are detailed in the text). The major efferent projections to the caudate/putamen and thalamus are from NBM as a whole(dark red arrow). All efferent projections are cholinergic. The diagram is based on axonal tracing experiments in primates (Mesulam et al., 1983; Russchen et al., 1985) ,immunohistochemical studies in rodents (Jones and Cuello, 1989) and pathological observations in human tissue (Mesulam and Geula, 1988) . Cx = abbreviation for 'cortex';NBM = nucleus basalis of Meynert (subsectors of NBM as described in main text); retic. formation = brainstem reticular formation; SNpc = substantia nigra pars compacta;VTA = ventral tegmental area.:
Immunohistochemical mapping in post-mortem brain tissuefrom healthy human subjects shows that efferent cholinergic pro-jections from the NBM leave the nucleus in two highly discreteorganized fibre bundles which form the medial and lateral cholin-ergic pathways ( Fig. 1) (Selden et al., 1998) . The cholinergic axonsin these bundles are mostly unmyelinated (Wainer and Mesulam,1990) . Both the human post-mortem studies and MRI diffusion ten-sor tractography in healthy volunteers demonstrate that the medialpathway leaves the NBM anteriorly and joins the white matter ofthe gyrus rectus. It curves round the rostrum of the corpus callosumto enter the cingulum, travels posteriorly to the splenium andenters the retrosplenial white matter to merge with fibres of thelateral pathway in the occipital lobe (Hong and Jang, 2010; Seldenet al., 1998) . Individual axons radiate from this pathway to supplythe medial orbitofrontal, subcallosal, cingulate, pericingulate andretrosplenial cortices. The lateral pathway subdivides into a capsu-lar division, travelling within the external capsule, and a perisylviandivision, travelling within the claustrum (Selden et al., 1998) . Onleaving the lateral aspect of NBM the capsular division gives offa bundle of fibres ventrally which travel in the white matter ofthe uncinate fasciculus to supply the amygdala and temporal lobecortices. The rest of the capsular division ascends in the externalcapsule adjacent to the putamen and its individual fibres radiateout to supply the dorsal frontoparietal cortex, middle and infe-rior temporal gyri, inferotemporal cortex and the parahippocampalgyrus. The perisylvian division courses within the claustrum intothe white matter of the inferior frontal and superior temporal gyri.From here its fibres radiate out to supply the frontoparietal opercu-lar cortices, superior temporal gyrus and the insula. The medial andlateral cholinergic pathways merge anteriorly in the white matterof the orbitofrontal gyri. These cortical projections from the NBMalso have a weak contralateral component (Mesulam et al., 1983) .These cholinergic projection fibres form a dense plexus inall regions of the human neocortex, displaying numerous end-terminal swellings which likely represent synaptic specializationsas they are often in intimate contact with cortical cholinocep-tive neurons (Mesulam and Geula, 1988) . There are differencesin the regional densities of NBM cortical innervations: limbic andparalimbic areas (particularly hippocampal, amygdala and piriformregions) receive substantially higher levels of cholinergic inputthan adjacent neocortical association areas. Apart from the cor-tex and amygdala both primate and human pathological studiesshow that the NBM also sends substantial efferent projections to anumber of diencephalic structures, including the caudate nucleus, putamen, thalamus ( Fig. 3 ) and habenular nucleus (via the striamedullaris) (Jones et al., 1976; Mesulam and Geula, 1988; Mesulamet al., 1992) .Overall, the heterogeneous neural input to NBM from predomi-nantly limbic structures combined with its dominant cholinergicoutput to the entire neocortex places it in a unique positionin the brain where it can influence all aspects of complexbehaviour according to the prevailing emotional or motivationalstate (Mesulam, 1987) .
MR IMAGING
 thin-section T2-weighted MR  same signal intensity as that of the gray matter  inferior to globus pallidus.  in substantia innominata of anterior perforated substance  substantia innominata has no clear anatomical borders at its anterior, posterior, and lateral extent Probabilistic maps of compartments of the basal forebrain magnocellular system are now available as an open source reference for correlation with fMRI, PET, and structural MRI data of the living human brain (Zaborsky 2008) Volume: normalized SI volume in normal subjects 1.68 ± 0.11 (Choi et al. 2012) The volume of the basal forebrain complex in the human brain varies from 58 to 154 mm3 [Grinberg and Heinsen, 2007; Halliday et al., 1993] .
Coronal (through the anterior commissure):  narrow band between the margin of subcommissural part of the globus pallidus and surface of the substantia innominata  rostrocaudal thickness of NBM -measured at the narrowest portion of the substantia innominata on the plane through the anterior commissure -about 2 mm.  immediately inferior to anterior commissure and superior and lateral to anterior portion of hypothalamus.
Anatomical borders:
superior -anterior commissure*, margin of subcommissural part of the globus pallidus *at the superior part of the posterior end of the anterior third of the substantia innominata inferior -surface of the substantia innominata (13 mm ventral from the superior edge of the anterior commissure at the midline?). anterior, posterior -6 mm anterior and 12 mm posterior from the middle of the anterior commissure.
NUCLEUS BASALIS OF MEYNERT
A136 (4) Our protocol for study: 4 mm anterior (2 AC widths) to AC; posterioranterior border of mammillary body medial -anterior portion of hypothalamus (25 mm lateral from the midline). laterallateral edge of GPe.
For NBM segmentation we are using the following anatomical borders:
superior -inferior margin of subcommissural part of the globus pallidus inferior -pial (basal) surface of the brain. anterior -two sagittal widths of anterior commissure anterior from the center of anterior commissure posterior -anterior border of mammillary bodies medial -medial border of the globus pallidus lateral -lateral edge of globus pallidus but sometimes it extends as far as putamen 
SUBNUCLEI OF BASAL FOREBRAIN
 Ch4al region has the strongest connections to wide-spread cortical areas in the human brain [Mesulam and Geula, 1988; Selden et al., 1998 ].  Teipel (2011) study suggests a sequence of atrophy from Ch4al to Ch4am and Ch2/3; Anatomy of the basal forebrain complex. 3D-reconstruction of the basal forebrain complex (BFC-view from anterior) from the brain of a 29year-old man who had died of pulmonary arrest [Grinberg and Heinsen, 2007] . The BFC is located within the substantia innominata that is delimited by the caudal rim of the ventral striatum, the ventral pallidum, the ventral parts of the internal capsule and the regions medial to the outlines of the anterior commissure. The BCF can be subdivided into four cell groups arranged in an arch-like path mainly beneath the anterior commissure:
Ch1 -medial septal nucleus
Ch2 -nucleus of vertical limb of the diagonal band of Broca.
Ch1-2 are called magnocellular cell groups within the septum.
Ch3 -nucleus of horizontal limb of the diagonal band of Broca;
Ch4 also called as the nucleus basalis of Meynert [Mesulam et al., 1983] or sublenticular part of the basal forebrain [Zaborsky 2008].
The nucleus subputaminalis, also called Ayala's nucleus, has only been described in the human brain so far [Heinsen et al., 2006; Simic et al., 1999] .
The volume of the BFC in the human brain varies from 58 to 154 mm3 [Grinberg and Heinsen, 2007; Halliday et al., 1993] .
NUCLEUS BASALIS OF MEYNERT
A136 (5) Talairach-Tournoux x/y/z coordinates Subnucleus Right Left Ch2/3 -5/6/-8 Ch4am 12/4/-10 Ch4al (lateral subst. innominata) 22 / 3-4 /-7 to -10 -17/5/-7 Ch4p (posterior subst. innominata) 24 / -11 / -8 Ch4i (medial subst. innominata) 4 / -2 / -7
x, the medial to lateral distance relative to midline (positive = right hemisphere); y, the anterior to posterior distance relative to the AC (positive = anterior); z, superior to inferior distance relative to the AC-PC line (positive = superior).
Zaborzsky 2008
HISTOLOGY Several postmortem studies have found that total number of nucleus basalis Meynert neurons in the nineth decade was 20-30% below that in newborns [Lowes-Hummel et al., 1989; Mann et al., 1984; McGeer et al., 1984] . 
NBM -very high magnification:
CLINICAL SIGNIFICANCE
In Parkinson' and Alzheimer's diseases, the nucleus basalis undergoes degeneration. A decrease in acetylcholine production is seen in Alzheimer's disease, Lewy body dementia, Pick's disease, and some Parkinson's disease patients showing abnormal brain function, leading to a general decrease in mental capacity and learning. Most pharmacological treatments of dementia focus on compensating for a faltering NBM function through artificially increasing acetylcholine levels. significant reductions of the substantia innominata in both AD and patients with Lewy bodies dementia, although the pattern of cortical atrophy is markedly different between both clinical populations [Whitwell et al., 2007] .
significantly increased risk to develop dementia was found over 4 years follow-up in cognitively normal subjects with atrophy of the basal forebrain at baseline [Hall et al., 2008] .
Cholinergic fibers innervating the cerebral cortex originate mainly from the NbM Ch4 region [Mesulam and Geula, 1988] , and their spatial distribution was determined in one seminal study of postmortem sections [Selden et al., 1998 ]. 
ROLE IN COGNITIVE DYSFUNCTION IN PD
PDD -PD with dementia.  prevalence of PDD -studies indicating a range of 19%-78% (Biggins et al., 1992; de Lau et al., 2005; Hobson and Meara, 2004; Levy et al., 2002) .  neural basis for cognitive dysfunctions in PD remains unknown.  PET study using imaging of cerebral acetyl cholinesterase demonstrated that cholinergic dysfunction occurs even in the early course of PD and is more widespread and profound in PDD (Hilker et al., 2005; Shimada et al., 2009 ).  basal forebrain pathology occurs simultaneously with nigral pathology (Braak et al. 2003, in a staging study of PD pathology). Haruo Hanyu, Tetsuichi Asano, Hirofumi Sakurai, Yuriko Tanaka, Masaru Takasaki, and Kimihiko Abe "MR Analysis of the Substantia Innominata in Normal Aging, Alzheimer Disease, and Other Types of Dementia" AJNR Am J Neuroradiol 23:27-32, January 2002  thickness of the substantia innominata was measured on the coronal T2-weighted image obtained through the anterior commissure: 1. 39 healthy control subjects (age range, 25-86 y; mean age, 62 y) -thickness of the substantia innominata significantly decreased with age 2. 39 patients with AD 3. 36 patients with non-AD dementia, including vascular dementia, frontotemporal dementia, and Parkinson disease with dementia.  compared with age-matched control subjects, both patients with AD and patients with non-AD dementia had significant atrophy of the substantia innominata:
HANYU
Probably "cm" (not "mm") but stillrostrocaudal thickness is about 2 cm  thickness of the substantia innominata significantly correlated with scores from the Mini-Mental State Examination in patients with AD but not in patients with non-AD dementia:
 MR imaging features in this structure may not be specific to AD.  no statistical differences were found between the thickness of the substantia innominata on the right and left sides in any subject.  in control subjects, the thickness of the substantia innominata significantly decreased with age (r = 0.86, P < 0.0001):
CHOI
Choi "Volumetric analysis of the substantia innominata in patients with Parkinson's disease according to cognitive status" Neurobiology of Aging 33 (2012) [1265] [1266] [1267] [1268] [1269] [1270] [1271] [1272] SI volume in PD differs depending on cognitive status and is significantly correlated with cognitive performance  MR-based volumetric analysis to evaluate the SI volume in PD-intact cognition (PD-IC, n = 24), PD-mild cognitive impairment (PD-MCI, n = 35), and PD dementia (PDD, n = 29).  mean normalized SI volume was significantly decreased in patients with PD-IC (1.54 ± 0.12, p < 0.001), PD-MCI (1.49 ± 0.12, p < 0.001), and PDD (1.39 ± 0.12, p < 0.001) compared with that of control subjects (1.68 ± 0.11).  normalized SI volume did not differ between patients with PD-IC and PD-MCI; however, the normalized SI volume was significantly decreased in patients with PDD compared with that in those with PD-IC (p < 0.001) or PD-MCI (p = 0.016).  normalized SI volume was significantly correlated with general cognitive status (r = 0.51, p < 0.001) as well as with performance in each cognitive subdomain, with a particularly significant independent association with attention (β = 0.33, p = 0.003) and object naming (β = 0.26, p = 0.017).
TEIPEL Teipel "The Cholinergic System in Mild Cognitive Impairment and Alzheimer's Disease: An In Vivo MRI and DTI study" Human Brain Mapping 32:1349 -1362 (2011 Correspondence to: Stefan J. Teipel, Department of Psychiatry and Psychotherapy, University Rostock, Gehlsheimer Str. 20, Rostock 18147, Germany. E-mail: stefan.teipel@med.uni-rostock.de AD Alzheimer's disease MCI -amnestic mild cognitive impairment, an at risk stage of AD.
 21 patients with AD + 16 subjects with MCI + 20 healthy elderly subjects  deformation-based morphometry of MRI scans.  3.0-Tesla Siemens scanner.  DTI imaging was performed with an echo-planar-imaging sequence (field-of-view: 256 mm; repetition time: 9,300 ms; echo time: 102 ms; voxel size: 2 x 2 x 2 mm3; four repeated acquisitions, b-value = 1,000, 12 directions, 64 slices, no overlap).  ROI -square aligned relative to the anterior commissure.  analysis -FSL.  assessed effects of basal forebrain atrophy on fiber tracts derived from high-resolution DTI using tract-based spatial statistics.  patients with AD and MCI subjects showed reduced volumes in basal forebrain areas corresponding to anterior medial and lateral, intermediate and posterior nuclei of the Nucleus basalis of Meynert (NbM) as well as in the diagonal band of Broca nuclei (P < 0.01).  study suggests a sequence of atrophy from Ch4al to Ch4am and Ch2/3; therefore, DTI study focused on tracts originating from Ch4al region  Effects in MCI subjects were spatially more restricted than in AD, but occurred at similar locations.  Effects were more pronounced in the right than the left hemisphere.  The volume of the right antero-lateral NbM nucleus was correlated with intracortical projecting fiber tract* integrity.
*such as the corpus callosum, cingulate, and the superior longitudinal, inferior longitudinal, inferior fronto-occipital, and uncinate fasciculus (P < 0.05, corrected for multiple comparisons).  Corticofugal fiber systems were spared (from atrophy).  correlation between atrophy and fiber tract changes was independent from cofactors such as age and MMSE score, as measure of disease severity.  there was no significant correlation between hippocampus atrophy and fiber tract integrity, underscoring the specificity of the findings for the BF  findings suggest that a multimodal MRI-DTI approach is supportive to determine atrophy of cholinergic nuclei and its effect on intracortical projecting fiber tracts in AD.
DBS OF NBM
Gratwicke et al. / Neuroscience and Biobehavioral Reviews 37 (2013):
humansThe first case report describing DBS for dementia in a patient wasperformed nearly thirty years ago and targeted the NBM. In 1984Turnbull et al. unilaterally implanted a flexible electrode into theleft NBM via a frontal approach in a 74-year old man with clinicallymoderate AD. Stimulation was delivered at relatively low frequency(bipolar, 3 V, 50 Hz, pulse width 210 ms) in cycles of 15 s on followedby 12 min off (Turnbull et al., 1985) . They did not observe any clin-ical improvement in cognition, however an arrest in the decline ofcortical metabolic activity was observed on the treated side over asix-month period compared to the unstimulated hemisphere. Con-clusions regarding the relevance of these metabolic changes mustbe guarded given the failure to show clinical improvement. Possiblemethodological factors limiting the clinical effect include unilateralshort-lasting and intermittent stimulation and that NBM targetingwas neither image nor pathologically verified, therefore accurateelectrode placement cannot be certain. In addition, the particularstimulus cycle chosen was unusual by today's standards given thatstimulation was only delivered for a total of 30 min in every 24 h.Following these uninspiring results the concept of DBS fordementia was shelved until more recently when Laxton et al.(2010) investigated the potential therapeutic use of DBS to treat ADthrough stimulation of the fornix. Having unexpectedly observedthat stimulation of this target evoked detailed autobiographicalmemories when attempting to modulate appetite in an obesepatient (Hamani et al., 2008) , they undertook a phase I trial offornix HFS (bilateral, bipolar, 3-3.5 V, 130 Hz, 90 _s) in six patientswith mild AD (Laxton et al., 2010) . sLORETA imaging showedthat this intervention activated ipsilateral medial temporal struc-tures within the memory circuit of Papez. However, no significantclinical benefit at the group level was reported. Nevertheless, con-sistent with the results of Turnbull et al. (1985) , chronic stimulationreversed depressed regional glucose metabolism in all patients,particularly in temporal and parietal cortices, indicating that DBSto different subcortical structures produces a common biologicaleffect (see Laxton and Lozano, 2012 for review).Another logical therapeutic strategy in dementia is to modulatefunction in medial temporal structures directly. However, severalexperiments show that direct LFS to the hippocampus has theopposite effect and actually acutely impairs recognition memoryin normal human subjects (Coleshill et al., 2004) , particularly dis-rupting the encoding phase (Lacruz et al., 2010) . However, Suthanaet al. have shown that acute LFS to neighbouring entorhinal cortexenhances spatial memory in cognitively normal human subjectswhen applied during the learning phase (Suthana et al., 2012) . Per-formance on a spatial navigation task improved by an average of64% across six subjects when LFS (bipolar, up to 3.0 V, 50 Hz, 300 _s)was applied to unilateral entorhinal cortex. Stimulation hereincreased theta power and theta-phase resetting in the ipsilateralhippocampal EEG (which is associated with new memory forma-tion as described above . In addition to these impairments healso displayed poor attention, rigid thinking, psychomotor slowingand apraxia. He underwent implantation of bilateral DBS electrodesinto the Ch4i subsector of NBM and monopolar LFS was initiated(1.0 V, 20 Hz, 120 _s). Ch4i was chosen as it is the largest subsectorof NBM (Fig. 2) (Mesulam and Geula, 1988) , therefore giving thehighest possibility of successful electrode placement. Moreover, ithas the most widespread cortical projections, giving the potentialto affect more cognitive domains ( Fig. 3 ) (Mesulam et al., 1983) .NBM DBS resulted in marked improvement in memory function:score on AVLT(sum) doubled to 25 indicating significant improve-ment in immediate episodic memory, and the patient was also ableto perform AVLT(recog) for the first time, recognizing six words,demonstrating some amelioration of long term memory function.Visual perceptual abilities increased with CDT score rising to 9 andTMT-A time falling to 2.5 min. Performance also improved on testsof processing speed and praxis, with additional benefits observed inattention, concentration, alertness, drive and spontaneity (Barnikolet al., 2010; Freund et al., 2009 ). All these cognitive benefits weresustained for two months during constant stimulation and wereshown to be time-locked to the cessation and reintroduction ofNBM stimulation, and thus dependent upon it. The authors com-mented that the overall enhancement in personality features andsocial communication of the patient with NBM DBS was moreimpressive than the testing of individual cognitive faculties andcritically improved overall quality of life.This latter report demonstrates that DBS of the NBM can beperformed safely in individuals with advanced dementia and alsoprovides preliminary results showing that this intervention maymarkedly improve cognitive functioning. That the patient receivedbenefit across several cognitive domains is in line with the hypothe-sis that activation of the NBM can enhance the behavioural state andthereby boost a range of mental faculties including memory, atten-tion and perception, although the exact mechanism by which thiswas achieved remains to be proven. Of course these results mustbe interpreted with caution since the long-term effects and efficacyof NBM DBS is still unknown, and may depend on the severity ofdisease.These single case results using LFS need to be replicatedin other patients by other teams and such trials are ongoing(www.clinicaltrials.gov). The major aims will be to establish theclinical efficacy of low frequency DBS of the NBM in dementia andto identify the specific patient characteristics that might indicate agreater likelihood of benefit, together with surgical targeting andtrajectory, stimulation parameters, and the possible utility of com-bining NBM DBS with electrical stimulation of other brain targets(particularly basal ganglia targets in PD patients).Dementia is a progressive disease and there is likely a limitedwindow of opportunity to stimulate the remaining NBM fibresbefore the nucleus becomes too degenerate for stimulation toenhance its output, therefore patients may need to be implantedearlier in the disease course. Patients suitable for NBM DBS trials arelikely to be those who have already tried cholinesterase inhibitors,have minimal cortical atrophy on imaging, lack significant co-morbidities and who have lucid intervals and capacity to consent.These considerations will reduce the risks of neurosurgery for thisvulnerable patient group and hopefully ensure the best outcomes. 
TRIALS
